drugset / Trial / NCT07850414
Intracameral Levofloxacin Versus Moxifloxacin After Cataract Surgery
RandomizedParallel-groupOpen-labelPrevention
Summary
This randomized study aims to compare the safety and efficacy of intracameral levofloxacin versus intracameral moxifloxacin administered at the end of phacoemulsification cataract surgery.
Timeline
- Start
- 2026-09-26
- Primary completion
- 2027-09-26
- Completion
- 2028-02-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levofloxacin | Small molecule | 0.1 ml | Other |
| Subject | Levofloxacin | Small molecule | 0.5 % | Other |
| Comparator | Moxifloxacin | Small molecule | 0.1 ml | Other |
| Comparator | Moxifloxacin | Small molecule | 0.5 % | Other |